Choosing a research peptide supplier means deciding whether the material and its supporting evidence meet the needs of your laboratory. A low price, a polished website or a prominently displayed purity percentage cannot answer that question alone.
Before ordering, check the exact product specification, batch-specific analytical results, traceability, storage information and delivery arrangements. The strongest supplier is one whose evidence you can examine and whose answers are specific to the material you will receive.
This guide is for laboratory procurement. It explains how to assess supplier documentation and where apparently reassuring claims need closer scrutiny.
Start with the research requirement
Write a short purchasing specification before comparing suppliers. Include the compound’s identity, required quantity, format and any analytical requirements determined by your laboratory’s protocol.
For example, does your experiment require a single compound or a mixture? Is a supplied solution compatible with your assay? Does the project require a measured concentration, or would a nominal amount be sufficient? Ask your scientific lead to resolve these questions before selecting a product.
Established peptide synthesis services offer different purity levels, modifications and formats for different applications. That is a useful reminder that “highest purity” is not a complete purchasing specification.[1]
Use the same requirements for every quotation. Otherwise, two similarly named products may represent materially different purchases.
1. Ask for a certificate of analysis for the relevant batch
A certificate of analysis, usually abbreviated to COA, should help you connect a product to its analytical results. A generic certificate on a website may illustrate the supplier’s testing approach, but it does not establish the results for the batch being offered.
As a documentation benchmark, FDA guidance referring to ICH Q7 identifies information such as the material’s name, batch number, release date, tests, acceptance limits and numerical results. That guidance concerns pharmaceutical active ingredients; it is not a statement that every laboratory research reagent is subject to those pharmaceutical requirements.[2]
For procurement purposes, request:
| Detail to check | Question it helps answer |
|---|---|
| Product name and specification | Does the report describe the material you intend to order? |
| Batch or lot identifier | Can the document be linked to the supplied container? |
| Report reference and dates | Can the report be identified and its timing understood? |
| Named testing organisation | Who performed the analysis? |
| Methods and actual results | What was measured, and what did the testing find? |
| Relevant acceptance criteria | What standard was used to assess the result? |
If the supplier cannot allocate a batch until dispatch, ask when the applicable COA will become available. On receipt, reconcile the label, delivery record and certificate before releasing the material for use.
2. Understand what a purity percentage measures
“99% purity” needs an accompanying method and a clear explanation of what the result represents.
Sigma-Aldrich distinguishes HPLC peptide purity from peptide content. In its explanation, the HPLC measurement compares the desired UK peptide with other detected components absorbing at the specified wavelength. Water and salts are not accounted for by that purity figure. Peptide content addresses how much of the overall sample consists of peptide material.[3]
Consequently, a high HPLC percentage does not, by itself, establish the mass of the intended peptide in a container.
Ask the supplier whether the stated milligram quantity refers to gross material, net peptide content or an independently measured amount of the target compound. For a supplied solution, ask how concentration was established.
The useful purchasing question is: “What does this number measure, and is that the measurement my experiment requires?”
3. Check identity separately from purity
A chromatographic purity result and an identity result address different questions. Request supporting identity evidence alongside the purity data, with enough information for your laboratory to review the conclusion.
Mass spectrometry is commonly used in peptide characterisation. Thermo Fisher’s peptide-mapping work illustrates how liquid chromatography and mass spectrometry can be combined to separate components and investigate their identities, including sequence confirmation.[4]
For purchasing decisions, ask what the supplier’s identity method actually establishes. Does the report provide an observed mass, a comparison with the expected result and, where needed, more detailed structural evidence? Avoid treating an unexplained “MS passed” statement as equivalent to a complete characterisation package.
A useful scientific example comes from research on synthetic human C-peptide: investigators used liquid chromatography–high-resolution mass spectrometry to identify and quantify structurally related peptide impurities. The study shows why characterisation can require more than a headline purity value; it does not establish that every commercial peptide requires that exact method.[5]
4. Look behind “independently tested” claims
Third-party testing is useful when the report, sample and supplied batch can be connected. Ask which laboratory performed the work, what was tested and whether the report can be authenticated through that laboratory.
Also ask who selected and submitted the sample. An independent analytical laboratory and independently controlled sampling are different parts of the evidence chain. A report on a submitted sample should not be treated as proof that every finished container has been individually tested.
If accreditation is claimed, check its scope. UKAS explains that accreditation applies to specific activities, which are listed in the organisation’s schedule. Accreditation for one type of testing does not automatically cover another.[6]
The practical check is whether the relevant method and material fall within the claimed scope. A laboratory logo alone is insufficient. Equally, the absence of accreditation does not by itself prove that a result is wrong; it means you need another basis for assessing the laboratory’s competence.
5. Establish whether testing covers the finished product
Ask whether the documents relate to the starting peptide, the formulated bulk material or the final product offered for sale.
This distinction is especially useful when comparing dry material with pre-mixed solutions or multi-compound blends. A starting-material report leaves additional questions about the finished formulation unanswered.
For a solution or blend, request the composition, concentration of each relevant component and the basis for any finished-product specifications. Ask which ingredients are present beyond the named peptide and whether the formulation is compatible with your laboratory method.
Record the answer in your purchasing file. If only starting-material data are available, assess that limitation explicitly rather than assuming the finished product has undergone the same testing.
6. Match additional tests to the experiment
Identity, chromatographic purity, peptide content and microbiological quality are separate characteristics. Do not interpret an HPLC purity figure as a sterility or endotoxin result.
Your laboratory should decide which additional specifications matter for the intended work. Possible questions include whether endotoxin, microbial contamination, residual solvents or other relevant impurities have been assessed. Request the actual test, units and acceptance criterion whenever one of these characteristics is important to your protocol.
Keep this assessment proportionate: a universal demand for every possible test can be as unhelpful as accepting a single purity number. The aim is to identify evidence that resolves the risks relevant to the experiment.
7. Request product-specific storage and stability information
Storage instructions should identify the product and its supplied form. Ask about unopened storage, handling after opening, expiry or retest dates, and any conditions attached to those dates.
A published consensus paper developed through the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium addresses peptide procurement, characterisation and handling for mass-spectrometry-based assays. It emphasises that appropriate storage and handling depend on the peptide sequence.[7]
That paper’s application-specific recommendations should not be converted into a blanket shelf-life claim for unrelated products. Instead, ask the supplier what evidence supports the conditions stated for the particular material or formulation.
For transport, request the expected shipping conditions and the procedure for assessing delays or temperature excursions. A cold pack or insulated box is a packaging choice; your purchasing decision should establish whether the transport arrangement is appropriate for the product.
8. Clarify what “UK supplier” means
Separate three practical questions:
- Which legal entity is selling and invoicing the product?
- Where is the material manufactured or formulated?
- Where will your order be dispatched from?
These locations may differ. A supplier serving UK laboratories may dispatch internationally, while a UK warehouse may hold material manufactured elsewhere.
Before paying, confirm the anticipated delivery window, who handles customs clearance where applicable, whether the quotation includes relevant charges and who resolves damaged or delayed deliveries. Request written terms for incorrect products, missing documents and quality complaints.
These checks support purchasing and scheduling; a particular country of manufacture does not substitute for product evidence.
Check out our article on whether peptides are legal in the UK.
9. Assess how the supplier handles uncertainty
Send one specific technical enquiry before placing a substantial order. For example: “Does this certificate cover the final formulation, and how was the stated concentration determined?”
Assess whether the response answers the question, provides a document or clearly identifies a limitation. An honest explanation that a test has not been performed is more useful to your purchasing decision than a broad assurance about exceptional quality.
Treat missing batch links, unverifiable reports, unexplained test results and conflicting specifications as reasons to pause and seek clarification. They are gaps in the evidence, rather than automatic proof of misconduct.
Keep research supply separate from medicinal claims
A research-use label does not establish that a product is authorised or suitable for human treatment.
The MHRA considers a product’s claims, properties, intended purpose and presentation when determining whether it is a medicine. Its assessment includes websites, advertising, packaging and other promotional material.[8]
The procurement implication is straightforward: do not use a laboratory supplier’s purity report or research disclaimer as evidence of clinical suitability. Where a project involves regulated medicinal use, obtain the appropriate regulatory and institutional advice for that project what to check and research before buying peptides.
A practical checklist before you order
Use this as an internal purchasing aid, not an accreditation scheme or scientific scoring system.
- Specification: The exact material, format and quantity meet the protocol.
- Batch evidence: The applicable COA will be available and linked to the delivered lot.
- Analytical meaning: Identity, purity and quantity claims are explained separately.
- Testing scope: You know whether the evidence covers starting material or the finished product.
- Laboratory evidence: Testing organisations and relevant accreditation claims can be checked.
- Storage and transport: Written instructions address the supplied product and foreseeable delivery issues.
- Commercial clarity: The seller, dispatch location, costs and complaint process are understood.
Keep the specification, correspondence and batch documents together. For repeat orders, confirm whether the batch or formulation has changed and review the relevant evidence again.
Reviewing Coridion Sciences products
When reviewing the research peptide range at Coridion Sciences, use the same checklist. Identify the product and format you need, then ask about the documentation and specifications relevant to your laboratory before ordering.
Clear purchasing requirements make it easier to establish whether the available evidence is sufficient—and to resolve unanswered questions before they affect an experiment.
Sources
- Thermo Fisher Scientific. Standard Peptide Custom Synthesis Service. Primary supplier information on purity, modifications and formats.
- US Food and Drug Administration. Questions and Answers on Current Good Manufacturing Practice Requirements: Control of Components and Drug Product Containers and Closures. See question 15 and its discussion of ICH Q7 certificate contents. Cited as a documentation benchmark, not as UK research-reagent law.
- Sigma-Aldrich. Peptide Sample Amount Determination. Technical explanation distinguishing chromatographic purity from peptide content.
- Thermo Fisher Scientific. High-Precision, Automated Peptide Mapping of Proteins. Primary application note illustrating complementary LC and MS analysis; not a universal supplier-testing standard.
- Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Original research, 2018. PubMed PMID: 29862433.
- UKAS. Accreditation vs Certification: What’s the difference?. Explanation of activity-specific accreditation and published schedules.
- Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays. Consensus recommendations, 2016. PubMed PMID: 26719571. Full text.
- Medicines and Healthcare products Regulatory Agency. Borderline products: how to tell if your product is a medicine. Official UK guidance, accessed 9 October 2026.